Chemical Biology & Drug Design

Cover image for Vol. 88 Issue 2

Edited By: David Selwood

Impact Factor: 2.802

ISI Journal Citation Reports © Ranking: 2015: 26/59 (Chemistry Medicinal); 137/289 (Biochemistry & Molecular Biology)

Online ISSN: 1747-0285

Recently Published Issues

See all

Editor's Choice

Bioinformatics prediction and in vitro analysis revealed that miR-17 targets Cyclin D1 mRNA in Triple Negative Breast Cancer cells

Fariba Karami, Samira Mohammadi-Yeganeh, Nairi Abedi, Ameneh Koochaki, Vahid Kia, Mahdi Paryan


miR-17 targets cyclin D1 which is involved in metastatic breast cancer. So, miR-17 is an attractive molecule that after intensive research can probably be used as a biomarker in TNBC.

This issue’s Editor’s Choice was chosen by David Selwood

Publish with CB & DD

Reasons to publish with CB & DD

• Rapid review and publishing: 30 days on average from submission to first decision. We discourage reviewers from requesting “additional experiments”.
• Simple initial submission process, can load a single PDF.
• We will consider any reasonable article format at this stage.
• Fully indexed in PubMed/MEDLINE, Chemical Abstracts etc.
• International editors from different specialities to oversee the review process.
• No page charges for first seven (typeset) pages, no charge for colour figures.
• Open Access publication option.
• Compliant to NIH, RCUK and other major funding bodies policies.

Submit your article now

News and Features

Meet the Editorial Team

We are pleased to announce that a member of our Editorial Board, Jurgen Bajorath, has won the 2015 Skolnik Award for his outstanding contributions to information science.

Most Accessed

Most Cited